Logo image
Clinical, genetic, and pathologic characterization of FKRP Mexican founder mutation c.1387A>G
Journal article   Open access   Peer reviewed

Clinical, genetic, and pathologic characterization of FKRP Mexican founder mutation c.1387A>G

Angela J Lee, Karra A Jones, Russell J Butterfield, Mary O Cox, Chamindra G Konersman, Carla Grosmann, Jose E Abdenur, Monica Boyer, Brent Beson, Ching Wang, …
Neurology. Genetics, Vol.5(2), pp.e315-e315
04/2019
DOI: 10.1212/NXG.0000000000000315
PMCID: PMC6454397
PMID: 31041397
url
https://doi.org/10.1212/NXG.0000000000000315View
Published (Version of record) Open Access

Abstract

To characterize the clinical phenotype, genetic origin, and muscle pathology of patients with the c.1387A>G mutation. Standardized clinical data were collected for all patients known to the authors with c.1387A>G mutations in . Muscle biopsies were reviewed and used for histopathology, immunostaining, Western blotting, and DNA extraction. Genetic analysis was performed on extracted DNA. We report the clinical phenotypes of 6 patients homozygous for the c.1387A>G mutation in . Onset of symptoms was <2 years, and 5 of the 6 patients never learned to walk. Brain MRIs were normal. Cognition was normal to mildly impaired. Microarray analysis of 5 homozygous c.1387A>G patients revealed a 500-kb region of shared homozygosity at 19q13.32, including . All 4 muscle biopsies available for review showed end-stage dystrophic pathology, near absence of glycosylated α-dystroglycan (α-DG) by immunofluorescence, and reduced molecular weight of α-DG compared with controls and patients with homozygous c.826C>A limb-girdle muscular dystrophy. The clinical features and muscle pathology in these newly reported patients homozygous for c.1387A>G confirm that this mutation causes congenital muscular dystrophy. The clinical severity might be explained by the greater reduction in α-DG glycosylation compared with that seen with the c.826C>A mutation. The shared region of homozygosity at 19q13.32 indicates that c.1387A>G is a founder mutation with an estimated age of 60 generations (∼1,200-1,500 years).

Details

Metrics

Logo image